Related references
Note: Only part of the references are listed.The Anti-Amyloid-beta Monoclonal Antibody 4G8 Recognizes a Generic Sequence-Independent Epitope Associated with alpha-Synuclein and Islet Amyloid Polypeptide Amyloid Fibrils
Asa Hatami et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Valproic Acid Modifies Synaptic Structure and Accelerates Neurite Outgrowth Via the Glycogen Synthase Kinase-3 Signaling Pathway in an Alzheimer's Disease Model
Zhi-Min Long et al.
CNS NEUROSCIENCE & THERAPEUTICS (2015)
Valproic Acid Alleviates Memory Deficits and Attenuates Amyloid-β Deposition in Transgenic Mouse Model of Alzheimer's Disease
Ai-Guo Xuan et al.
MOLECULAR NEUROBIOLOGY (2015)
Valproate Improves Memory Deficits in an Alzheimer's disease Mouse Model: Investigation of Possible Mechanisms of Action
Zhi-Gang Yao et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2014)
Valproic Acid Reduces Neuritic Plaque Formation and Improves Learning Deficits in APPSwe/PS1A246E Transgenic Mice via Preventing the Prenatal Hypoxia-Induced Down-Regulation of Neprilysin
Zheng Wang et al.
CNS NEUROSCIENCE & THERAPEUTICS (2014)
Valproic Acid Attenuates Neuronal Loss in the Brain of APP/PS1 Double Transgenic Alzheimer's Disease Mice Model
Zhimin Long et al.
CURRENT ALZHEIMER RESEARCH (2013)
Effect of Sodium Valproate Administration on Brain Neprilysin Expression and Memory in Rats
Natalia N. Nalivaeva et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2012)
Activation of glycogen synthase kinase-3 beta mediates β-amyloid induced neuritic damage in Alzheimer's disease
B. DaRocha-Souto et al.
NEUROBIOLOGY OF DISEASE (2012)
Valproate reduces tau phosphorylation via cyclin-dependent kinase 5 and glycogen synthase kinase 3 signaling pathways
Jiang-Ping Hu et al.
BRAIN RESEARCH BULLETIN (2011)
Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease
David Prvulovic et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2011)
Inhibition of Glycogen Synthase Kinase-3β by Angelica sinensis Extract Decreases β-Amyloid-Induced Neurotoxicity and Tau Phosphorylation in Cultured Cortical Neurons
Zhaoxu Zhang et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2011)
Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease
Marcello D'Amelio et al.
NATURE NEUROSCIENCE (2011)
FEAR CONDITIONING IS ASSOCIATED WITH DYNAMIC DIRECTED FUNCTIONAL INTERACTIONS BETWEEN AND WITHIN THE HUMAN AMYGDALA, HIPPOCAMPUS, AND FRONTAL LOBE
C. C. Liu et al.
NEUROSCIENCE (2011)
Hippocampal Synaptic Plasticity, Memory, and Epilepsy: Effects of Long-Term Valproic Acid Treatment
Carmelo Sgobio et al.
BIOLOGICAL PSYCHIATRY (2010)
Valproic acid as a promising agent to combat Alzheimer's disease
Xiu-Zhen Zhang et al.
BRAIN RESEARCH BULLETIN (2010)
Glycogen Synthase Kinase-3 (GSK-3) Inhibitors for the Treatment of Alzheimer's Disease
Miguel Medina et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Hysterectomy, Oophorectomy and Risk of Dementia: A Nationwide Historical Cohort Study
Thien Kieu Thi Phung et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2010)
Alzheimer Disease
Rudy J. Castellani et al.
DM DISEASE-A-MONTH (2010)
Caspase activation precedes and leads to tangles
Alix de Calignon et al.
NATURE (2010)
The Genetics of Alzheimer Disease: Back to the Future
Lars Bertram et al.
NEURON (2010)
Alzheimer's disease: new approaches to drug discovery
Maria L. Bolognesi et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2009)
Multipotent natural agents to combat Alzheimer's disease. Functional spectrum and structural features
Hong-fang Ji et al.
ACTA PHARMACOLOGICA SINICA (2008)
Pavlovian fear conditioning as a behavioral assay for hippocampus and amygdala function: cautions and caveats
Stephen Maren
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Valproic acid inhibits Aβ production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models
Hong Qing et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Gender and education impact on brain aging: A general cognitive factor approach
Cecile Proust-Lima et al.
PSYCHOLOGY AND AGING (2008)
Synaptic plasticity: Multiple forms, functions, and mechanisms
Ami Citri et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: Multiple mechanisms of action
Hyeon Ju Kim et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment
S. W. Scheff et al.
NEUROLOGY (2007)
Effects of interleukin-1β and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests
Artur H. Swiergiel et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2007)
Regulation and function of glycogen synthase kinase-3 isoforms in neuronal survival
Min-Huei Liang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes
P-S Chen et al.
MOLECULAR PSYCHIATRY (2006)
Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions
Richard S. Jope et al.
CURRENT DRUG TARGETS (2006)
Transgenic mouse models for Alzheimer's disease:: the role of GSK-3β in combined amyloid and tau-pathology
D. Muyllaert et al.
REVUE NEUROLOGIQUE (2006)
Endogenous α-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity
Yan Leng et al.
JOURNAL OF NEUROSCIENCE (2006)
The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways
Eleonore Beurel et al.
PROGRESS IN NEUROBIOLOGY (2006)
Different conformations of amyloid β induce neurotoxicity by distinct mechanisms in human cortical neurons
Atul Deshpande et al.
JOURNAL OF NEUROSCIENCE (2006)
Sex differences in the clinical manifestations of Alzheimer disease pathology
LL Barnes et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Effects of valproic acid derivatives on inositol trisphosphate depletion, teratogenicity, glycogen synthase kinase-3β inhibition, and viral replication:: A screening approach for new bipolar disorder drugs derived from the valproic acid core structure
BJ Eickholt et al.
MOLECULAR PHARMACOLOGY (2005)
Influence of sodium valproate on sodium and chloride urinary excretion in rats, gender differences
J Grikiniene et al.
PHARMACOLOGY (2005)
Valproic acid, a mood stabilizer and anticonvulsant, protects rat cerebral cortical neurons from spontaneous cell death: a role of histone deacetylase inhibition
MR Jeong et al.
FEBS LETTERS (2003)
A common mechanism of action for three mood-stabilizing drugs
RSB Williams et al.
NATURE (2002)
Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen
CJ Phiel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Augmented senile plaque load in aged female β-amyloid precursor protein-transgenic mice
MJ Callahan et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Share Paper
